We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current CDMOP market cap is 1.58B. The company's latest EPS is USD 0.0089 and P/E is 610.11.
| Quarter End | Jul 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36.69M | 34.76M | 38.02M | 39.8M | 37.73M |
| Operating Income | 2.74M | -2.68M | 2.72M | 832k | -2.16M |
| Net Income | 1.56M | -1.16M | 461k | -309k | -2.09M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 53.6M | 59.7M | 95.87M | 119.6M | 149.27M |
| Operating Income | -5.62M | -10.94M | 12.24M | 15.42M | 3.6M |
| Net Income | -8.9M | -15.15M | 3.32M | 127.67M | 560k |
| Quarter End | Jul 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 451.22M | 441.85M | 450.43M | 451.05M | 442.34M |
| Total Liabilities | 272.22M | 260.66M | 265.04M | 261.58M | 251.74M |
| Total Equity | 179M | 181.2M | 185.4M | 189.47M | 190.6M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 78.4M | 107.62M | 265.51M | 429.84M | 451.05M |
| Total Liabilities | 25.33M | 65.72M | 187.77M | 255.32M | 261.58M |
| Total Equity | 53.07M | 41.9M | 77.74M | 174.53M | 189.47M |
| Quarter End | Jul 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.03M | -8.77M | -15.69M | -12.89M | -278k |
| Investing | -6.92M | -41.43M | -52.76M | -77.64M | -14.11M |
| Financing | 929k | 1.33M | 2.2M | 2.9M | 748k |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.6M | 5.83M | 31.18M | 9.47M | -12.89M |
| Investing | 4.54M | -3.81M | -9.86M | -56.41M | -77.64M |
| Financing | -2.86M | 1.1M | 112.34M | 3.2M | 2.9M |
| Market Cap | 1.58B |
| Price to Earnings Ratio | 610.11 |
| Price to Sales Ratio | 2.3 |
| Price to Cash Ratio | 8.89 |
| Price to Book Ratio | 1.81 |
| Dividend Yield | - |
| Shares Outstanding | 63.11M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 8 (30.77%) |
| Company Name | Avid Bioservices Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.peregrineinc.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
